Landmark Plans Accelerate Breakthroughs in Rare Disease Treatments
Rare disease treatments are set to advance significantly as the Medicines and Healthcare products Regulatory Agency (MHRA) initiates a groundbreaking public consultation. This proposed regulatory framework aims to accelerate the development of therapies for rare...
Read moreDetails















































